These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 10562787

  • 1. Effects of non-depolarizing neuromuscular blocking agents on norepinephrine release from human atrial tissue obtained during cardiac surgery.
    Sato K, Windisch K, Matko I, Vizi ES.
    Br J Anaesth; 1999 Jun; 82(6):904-9. PubMed ID: 10562787
    [Abstract] [Full Text] [Related]

  • 2. The effect of non-depolarizing neuromuscular blocking agents on the release of acetylcholine from the right atrium of the guinea pig.
    Manabe N.
    Acta Med Okayama; 1997 Feb; 51(1):13-8. PubMed ID: 9057930
    [Abstract] [Full Text] [Related]

  • 3. Direct evidence that pancuronium and gallamine enhance the release of norepinephrine from the atrial sympathetic nerve by inhibiting prejunctional muscarinic receptors.
    Kobayashi O, Nagashima H, Duncalf D, Chaudhry IA, Harsing LG, Foldes FF, Goldiner PL, Vizi ES.
    J Auton Nerv Syst; 1987 Jan; 18(1):55-60. PubMed ID: 2880888
    [Abstract] [Full Text] [Related]

  • 4. Cardiac effects of non-depolarizing neuromuscular blocking agents pancuronium,vecuronium, and rocuronium in isolated rat atria.
    Melnikov AL, Malakhov KY, Helgesen KG, Lathrop DA.
    Gen Pharmacol; 1999 Oct; 33(4):313-7. PubMed ID: 10523069
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors.
    Cembala TM, Forde SC, Appadu BL, Lambert DG.
    Eur J Pharmacol; 2007 Aug 13; 569(1-2):37-40. PubMed ID: 17588565
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical experiences with pipecuronium bromide.
    Boros M, Szenohradszky J, Kertész A, Marosi G, Tutsek L.
    Acta Chir Hung; 1983 Aug 13; 24(4):207-14. PubMed ID: 6322488
    [Abstract] [Full Text] [Related]

  • 19. Pancuronium and renal perfusion: a comparison of neuromuscular blocking agents.
    Leighton KM, Koth B, Bruce C.
    Can Anaesth Soc J; 1974 Mar 13; 21(2):131-8. PubMed ID: 4274253
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.